Life Sciences: IP/Patent Litigation | USA

DLA Piper LLP houses a highly regarded practice with a strong international presence highlighted for its guidance on the management of IP portfolios and on corporate transactions and stock offerings. The team is also recognized for its contentious work, such as patent disputes and patent office actions. The firm has additional expertise in medical device product liability litigation and corporate governance matters including anti-takeover measures and proxy contests.

Mintz Levin Cohn Ferris Glovsky and Popeo PC boasts a strong team of dedicated attorneys proficient in IP prosecution, litigation and strategy. Representing established and emerging companies, the firm has broad experience within the biotechnology and life sciences sectors.

Irell & Manella LLP is a litigation boutique recommended for its bench of seasoned trial lawyers providing adept representation in patent infringement and inventorship disputes. The firm is well regarded for its capabilities in representing life sciences clients in inter partes reviews at the PTAB. It also advises on transactions in the sector, such as patent licensing, Hatch-Waxman and M&A.

Jones Day supports both emerging and well-established pharmaceutical, medical device and healthcare companies on a host of IP issues. The group is called upon to advise on patent prosecution and portfolio strategy, as well as high stakes litigation.

Orrick, Herrington & Sutcliffe has a highly sought after IP group with the ability to handle complex disputes including Hatch-Waxman litigation and patent infringement claims. The firm also assists manufacturers, investors and drug and medical device companies with IP strategies and collaborations.

Quinn Emanuel Urquhart & Sullivan LLP is a respected litigation firm with a notable track record of success in complex IP disputes for emerging and established life sciences companies. The group frequently handles bet-the-company patent disputes, as well as related matters before the PTAB.